Dcatvci.org

Single-Payer Healthcare: Good or Bad for Rx Drugs

WEBPrescription drugs accounted for about 10% of personal healthcare spending nationally in the US in 2017, which is substantially smaller than the share of such …

Actived: 2 days ago

URL: https://www.dcatvci.org/features/single-payer-healthcare-good-or-bad-for-rx-drugs/

The US and the Bio/Pharma Supply Chain: What’s Next

WEBThe bio/pharma industry and the supply chain The bio/pharma industry was highlighted in the White House briefing as one of the industries in which the Biden …

Category:  Health Go Health

What’s Next for the New GSK After Consumer Healthcare Spin-off

WEBWhat is next for the New GSK? This week (July 18, 2022), GlaxoSmithKline completed the spin-off its consumer healthcare business to form a separate stand-alone, …

Category:  Health Go Health

Pharma Industry Outlook: Where is the Growth

WEBGraham Lewis, Vice President, Global Pharma Strategy, IQVIA, gave a bio/pharma market overview at DCAT Week and outlined what lies ahead for the …

Category:  Health Go Health

The EU: Manufacturing and Preparing for the Next Health Emergency

WEBRole of HERA. Part of that EUR 50 billion ($59 billion) investment will be used to fund the newly established European Health Emergency preparedness and …

Category:  Health Go Health

Organon: What’s Next for the New Merck & Co. Spin-off

WEBThe new company consists of approximately 9,000 employees, which represented 12% of Merck’s global workforce as of December 31, 2020. In its second …

Category:  Health Go Health

Inside the New J&J and Consumer Health Company

WEBThe new J&J, focused on pharmaceutical and medical devices, is expected to have full-year 2021 revenues of approximately $77 billion, and the planned new …

Category:  Medical Go Health

The New Health Economy: What's the Impact on the …

WEBIn its annual report, “Top Health Industry Issues for 2016,” PwC's HRI highlights the top 10 forces that are expected to have the most impact on the industry in …

Category:  Health Go Health

The CDMO/CMO Report: Cell and Gene Therapies

WEBWith an investment of more than $250 million, construction of the new 710,000-square-foot site is expected to be completed by the end of 2024. The space …

Category:  Health Go Health

The Pharma Industry and Trade: What Issues Are on the Policy …

WEBIn its comments, PhRMA cites data that assert that in 2014, biopharmaceutical research and development activity added more than $1.2 trillion to …

Category:  Health Go Health

IMS Provides Improved Outlook for Global Pharmaceutical Market …

WEBLed by the US and Pharmerging markets, a term used by IMS to denote the most promising emerging markets, the global pharmaceutical market is projected to …

Category:  Health Go Health

The Latest in the Battle for US Drug-Pricing Reform

WEBThe House of Representatives passed a drug-pricing reform bill in December 2019, the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3), which did …

Category:  Health Go Health

Novartis, GlaxoSmithKline in Major Three-Part Deal for Oncology, …

WEBNovartis has reached a definitive agreement with GlaxoSmithKline plc (GSK) in a three-part transaction to acquire GSK’s oncology products, to divest its vaccine …

Category:  Health Go Health

Global Briefs: Bausch Health, ADC Therapeutics, Viatris & More

WEBEmergent To Acquire Rights to Oral Smallpox Drug in $337.5-M Deal Emergent BioSolutions, a Gaithersburg, Maryland-based specialty biopharmaceutical …

Category:  Health Go Health

Market Watch: Cell and Gene Therapies, Niche But Growing

WEBThree companies raised between $100 million and $200 million in 2020. They were: Taysha Gene Therapeutics, a Dallas, Texas-based company developing gene …

Category:  Health Go Health

Danaher Completes $21.4-Bn Acquisition of GE Healthcare Life …

WEBDanaher, a global science and technology company, headquartered in Washington D.C., has completed its $21.4-billion acquisition of the biopharma business …

Category:  Health Go Health

Lonza, BSP Pharmaceuticals Expand; Aptar Acquires Cohero Health

WEBMinaris To Invest $64.5 M To Expand Mfg for Cell, Gene Therapies. Minaris Regenerative Medicine, a CDMO of cell and gene therapies, plans to invest $64.5 …

Category:  Medicine Go Health

Merck & Co. To Move Global HQ; Names Organon as New Spin-off

WEBMerck & Co. plans to consolidate its New Jersey campuses into a single New Jersey headquarters location in Rahway by the end of 2023. Additionally, the …

Category:  Health Go Health

Bausch Health Reaches $1.2-Billion Settlement in Securities Litigation

WEBBausch Health (formerly Valent Pharmaceuticals) has reached a $1.21-billion settlement in putative securities class action litigation initially brought against …

Category:  Health Go Health